Explore
Validate
LearnMAB1268
antibody from R&D Systems
Targeting: SERPINA1
A1A, A1AT, AAT, alpha-1-antitrypsin, alpha1AT, PI, PI1
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [2]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- MAB1268 - Provider product page
- Provider
- R&D Systems
- Product name
- Anti-Human Serpin A1/alpha 1-Antitrypsin Monoclonal Antibody (Clone 202808)
- Antibody type
- Monoclonal
- Antigen
- Mouse myeloma cell line NS0-derived recombinant human Serpin A1/α1‑Antitrypsin, Glu25-Lys418
- Description
- Protein A or G purified from hybridoma culture supernatant
- Reactivity
- Human
- Host
- Mouse
- Antigen sequence
P01009- Isotype
- IgG
- Vial size
- 500 µg
Submitted references Modified serpinA1 as risk marker for Parkinson's disease dementia: Analysis of baseline data.
Maggot chymotrypsin I from Lucilia sericata is resistant to endogenous wound protease inhibitors.
Halbgebauer S, Nagl M, Klafki H, Haußmann U, Steinacker P, Oeckl P, Kassubek J, Pinkhardt E, Ludolph AC, Soininen H, Herukka SK, Wiltfang J, Otto M
Scientific reports 2016 May 17;6:26145
Scientific reports 2016 May 17;6:26145
Maggot chymotrypsin I from Lucilia sericata is resistant to endogenous wound protease inhibitors.
Telford G, Brown AP, Kind A, English JS, Pritchard DI
The British journal of dermatology 2011 Jan;164(1):192-6
The British journal of dermatology 2011 Jan;164(1):192-6
No comments: Submit comment
No validations: Submit validation data